Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas

		Keywords:		Enzastaurin , Bevacizumab

		Phase:		Phase 2

		Treatment ID#s:		VT1912 NCT00586508

		Age Group:		Adults Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		04/21/2009

		Tumor Types:		Anaplastic Astrocytoma Glioblastoma Multiforme


		Comments:

		Treatment Type:		Chemotherapy Less-Toxics.

		Contact:		National Cancer Institute NCI Cheryl Royce, CRNP, Clinical Director Neuro-oncology Branch 9030 Old Georgetown Road Bethesda, MD 20892 Phone:866-251-9686 Click here to send an email Website: home.ccr.cancer.gov/nob/

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By